Tumours pick the path to cancer inflammation
- 26 August 2019
- journal article
- editorial
- Published by Springer Nature in Nature Cell Biology
- Vol. 21 (9) , 1055-1057
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanismsNature Cell Biology, 2019
- Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasisNature, 2019
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast CancerNew England Journal of Medicine, 2018
- Understanding the tumor immune microenvironment (TIME) for effective therapyNature Medicine, 2018
- Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast CarcinomasCancer Research, 2017
- Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysisBreast Cancer Research, 2017
- The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-AnalysisPLOS ONE, 2016
- Classification of current anticancer immunotherapiesOncotarget, 2014
- Cancer-related inflammation and treatment effectivenessThe Lancet Oncology, 2014
- Tumor-Associated Macrophages: From Mechanisms to TherapyImmunity, 2014